Sesen Bio

$2.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-7.94%) Today
+$0.03 (+1.29%) As of 9:57 PM UTC after-hours

Why Robinhood?

You can buy or sell Sesen Bio and other stocks, options, and ETFs commission-free!

About SESN

Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells.

CEO
Thomas R. Cannell
Employees
27
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
409.60M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.45M
High Today
$2.50
Low Today
$2.25
Open Price
$2.45
Volume
7.20M
52 Week High
$3.57
52 Week Low
$0.51

SESN Earnings

-$0.32
-$0.11
$0.10
$0.31
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

WMB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure